We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Pistachio-Rich Diet Lowers Cholesterol and Decreases Risk of Cardiovascular Disease

By LabMedica International staff writers
Posted on 13 Oct 2008
Cardiovascular disease researchers have identified a molecular mechanism that mediates the reduction in cholesterol induced by a diet rich in pistachio nuts.

In July 2003, the [U.S.] Food and Drug Administration (FDA) (Bethesda, MD, USA) approved the first qualified health claim specific to nuts lowering the risk of heart disease: "Scientific evidence suggests but does not prove that eating 1.5 ounces per day of most nuts, such as pistachios, as part of a diet low in saturated fat and cholesterol may reduce the risk of heart disease.”

Pennsylvania State University (State College, PA, USA) for many years has been in the forefront of efforts to understand the effect of a pistachio rich diet on lipid metabolism. More...
In the current study, published in the September 2008 issue of the American Journal of Clinical Nutrition, investigators at Penn State evaluated the effects of two doses of pistachios, added to a lower-fat diet, on lipids and lipoproteins, apolipoprotein subclasses, and plasma fatty acids. To investigate the mechanisms of action, they measured cholesteryl ester transfer protein and indexes of plasma stearoyl-CoA desaturase activity (SCD).

In the study, half the pistachios were incorporated into meals while the remainder was eaten over the course of the day as a snack. Results showed that compared to a low fat control diet without pistachios, a 20% (of caloric intake) pistachio diet lowered low-density lipoprotein (LDL) cholesterol about 12%, and a 10% pistachio diet lowered LDL cholesterol by 9%. These results corresponded to a 9 to 12% decrease in coronary heart disease risk.

Evaluation of fatty acid composition showed that as a result of the high pistachio diet, the activity of SCD was reduced, and that the ratio of 16:1/16:0 fatty acids was significantly lower than in those on the control diet. "Our study has shown that pistachios, eaten with a heart healthy diet, may decrease a person's CVD risk profile,” said senior author Dr. Penny Kris-Etherton, professor of nutrition at Pennsylvania State University.”

Related Links:
Pennsylvania State University
Food and Drug Administration


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.